Royal Sense Ltd. · BSE:ROYAL

Royal Sense — Investor Presentation (February 2024)

24 slides from Royal Sense's investor presentation, February 2024

  1. Slide 1: Investor Presentation

    INVESTOR PRESENTATION www.royalsense.in INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024

  2. Slide 2: Index

    INDEX CORPORATE OVERVIEW BUSINESS OVERVIEW FINANCIAL PERFORMANCE IPO DETAILS www.royalsense.in INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024 03 02

  3. Slide 3: Corporate Overview

    CORPORATE OVERVIEW COMPANY SNAPSHOT ABOUT COMPANY OVERVIEW JOURNEY / MILESTONES TEAM / KEY MANAGEMENT www.royalsense.in INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024 03

  4. Slide 4: Company Snapshot

    CORPORATE OVERVIEW COMPANY SNAPSHOT Promoters Product Return on 20 Years Experience 100% Purity 16.72% Capital Employed* EBITDA 20k+ Satisfied Customers 803.26 Total Revenue* 11.86% Margin* 1800+ Products 70.28 Profit after Tax* 8.75% PAT Margin* *6 months ended September 2023 04 03 INVESTOR ROYAL F

  5. Slide 5: Overview

    CORPORATE OVERVIEW OVERVIEW FINANCIAL HIGHLIGHTS FY 2020-21* FY 2021-22* FY 2022-23* FY 2023 ENDED SEPT 30 REVENUE FROM OPERATIONS 713.51 674.86 1,156.46 803.26 EBIDTA 23.25 22.64 136.28 95.26 EBIDTA (%) 3.26 3.35 11.78 11.90 PAT 21.43 21.84 131.78 70.28 PAT (%) 3.00 3.24 11.40 8.75 NET-WORTH 415.29

  6. Slide 6: About Company

    CORPORATE OVERVIEW ABOUT COMPANY At Royal Sense Limited, we stand at the intersection of technology and medicine, delivering advanced solutions that redefine patient care and elevate medical practices. We are a leading force in the realm of medical devices dedicated to transforming healthcare throug

  7. Slide 7: Journey/Milestones

    CORPORATE OVERVIEW JOURNEY/MILESTONES 2015 Royal Traders embarked on its journey in 2015 under proprietorship 2020 as M/s Royal Traders with a vision Building on its success and strategic to revolutionize the medical foresight, Royal Traders continued consumables industry, particularly its expansion

  8. Slide 8: Team/Key Management

    CORPORATE OVERVIEW TEAM/KEY MANAGEMENT BOARD OF DIRECTORS Rishabh Arora Harmeet Singh Vikas Mukta Ahuja Amit Singh Tomar Managing Director & CFO Whole Time Director Non-Executive Director Independent Director Independent Director Mr. Rishabh Arora, aged 39 years, is the Mr. Harmeet Singh, aged 39 Mr

  9. Slide 9: Business Overview

    BUSINESS OVERVIEW SECTOR OVERVIEW BUSINESS OVERVIEW BUSINESS SEGMENTS KEY PRODUCTS OUR PRESENCE CLIENTELE www.royalsense.in INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024 09 03

  10. Slide 10: Sector Overview

    BUSINESS OVERVIEW SECTOR OVERVIEW The Indian medical devices industry is currently valued at around US$ 5 billion which is 2% of the US$ 250 billion Indian market for industries. The overall healthcare industry in India is valued at USD 90 Billion which is expected to reach US$ 220 US$ medical equip

  11. Slide 11: Business Overview

    BUSINESS OVERVIEW BUSINESS OVERVIEW We “Royal Sense” are suppliers of high quality goods OUR STRENGTHS OUR STRATEGY that meet international standards required for hospitals, laboratories, institutions and clinics to Experience Focus on provide health services. We trade and offer a wide range of surg

  12. Slide 12: Business Segments

    BUSINESS OVERVIEW BUSINESS SEGMENTS THE HEALTHCARE MARKET FUNCTIONS THROUGH FIVE SEGMENTS HEALTHCARE Hospitals Pharmaceutical Diagnostics Medical equipment Medical insurance Telemedicine and supplies • Government It includes It comprises It includes It includes health Telemedicine has Hospitals - It

  13. Slide 13: Key Products

    BUSINESS OVERVIEW KEY PRODUCTS PRODUCTS WE DEAL IN 1. Catgut Plain Suture 8. Black Braided Silk 15. Surgical Blade 2. Chromic Catgut Suture 9. Polyamide Sutures 16. IV (Intravenous) Cannula 3. Polyglactin 910 Suture 10. Polyester Sutures 17. Sharp Container 4. Polyglactin Fast Absorbable 11. Polypro

  14. Slide 14: Our Presence

    BUSINESS OVERVIEW OUR PRESENCE JAMMU & KASHMIR HIMACHAL PRADESH PUNJAB UTTARAKHAND HARYANA DELHI BIHAR UTTAR PRADESH GUJARAT MADHYAPRADESH MAHARASHTRA TELANGANA CHATTISGARH KERALA TAMILNADU 03 14 INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024

  15. Slide 15: Clientele

    BUSINESS OVERVIEW CLIENTELE AIIMS INDIAN ARMY BSF ESIC HBCH ICMR IHBAS INDIAN RAILWAYS NEIGRIHMS DR. RAM MANOHAR LOHIA HOSPITAL AND PGIMER 15 03 INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024

  16. Slide 16: Financial Performance

    FINANCIAL PERFORMANCE REVENUE MODEL FINANCIAL PERFORMANCE www.royalsense.in INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024 03 16

  17. Slide 17: Revenue Model

    FINANCIAL PERFORMANCE REVENUE MODEL General consumables 461.20 Lakhs Total 57% 803.26 Revenue FY23 Suture 139.19 Lakhs Lakhs (As on Sept 23) 17% Surgical/Medical devices 131.63 Lakhs 16% 800+ Medicine 62.89 Lakhs SKUs 9% Others 8.35 Lakhs 1% 03 17 INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024

  18. Slide 18: Financial Performance

    FINANCIAL PERFORMANCE FINANCIAL PERFORMANCE REVENUE EBIDTA% PAT% 713.51 674.86 1,156.46 803.26 3.26 3.35 11.78 11.90 3.00 3.24 11.40 8.75 27.31% 90.09% 94.94% CAGR CAGR CAGR 3 Years 3 Years 3 Years FY FY FY FY FY FY FY FY FY FY FY FY 2020-21 2021-22 2022-23 2023 2020-21 2021-22 2022-23 2023 2020-21

  19. Slide 19: Investment Rationale

    INVESTMENT RATIONALE OBJECT OF THE ISSUE IPO DETAILS INVESTMENT RATIONALE IPO INTERMEDIARIES CONTACT SLIDE (WITH DISCLAIMER) www.royalsense.in INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024 03 19

  20. Slide 20: Object of the Issue

    INVESTMENT RATIONALE OBJECT OF THE ISSUE Amount Percentage (INR in Lakhs) Working Capital Requirements 600.00 60.85% General Corporate Purposes 240.00 24.34% Issue Expenses 146.00 14.81% TOTAL 986.00 100.00% 20 03 INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024

  21. Slide 21: IPO Details

    INVESTMENT RATIONALE IPO DETAILS Issue Open 12th March, 2024 Issue Close 14th March, 2024 Number of shares 14,50,000 Issue size 9.86 Cr Fixed price 68 Lot size 2000 Listing on BSE SME Registrar Big Share Services Private Limited 03 21 INVESTOR ROYAL FEBRUARY PRESENTATION SENSE LTD 2024

  22. Slide 22: Investment Rationale

    INVESTMENT RATIONALE INVESTMENT RATIONALE zeel data taken Ÿ Cash balances are greater than debt Ÿ Diverse range of products, more than 800+ SKUs Ÿ High and stable margins Ÿ Exclusive dealership rights for Ÿ Limited players in the industry products under brand name Ÿ Return on net worth is around 17%

  23. Slide 23: IPO Intermediaries

    INVESTMENT RATIONALE IPO INTERMEDIARIES LEAD MANAGER OF THE ISSUE REGISTRAR TO THE ISSUE LEGAL ADVISOR TO THE ISSUE STATUTORY AUDITORS Expert Global Consultants Private Limited Bigshare Services Private Limited Mr. Parvinder Nautiyal Tattvam & CO. 1511, RG Trade Tower Netaji Subhash Place, S6-2, 6th

  24. Slide 24: Contact

    INVESTMENT RATIONALE CONTACT RISHABH ARORA GAURAVJAIN +91 98705 85865 +91 98911 11234 [email protected] [email protected] ROYAL SENSE LIMITED EXPERT GLOBAL CONSULTANTS PRIVATE LIMITED Registered Office: Plot No - 57, First Floor, 1511, RG TradeTower, Netaji Subhash Place, Phase - 2,

Royal Sense — Investor Presentation (February 2024) on 6ix